Serum fibroblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients

Nephrology Dialysis Transplantation

Volumn 26, Issue 4, 2011, Pages 1346-1354

  Kirkpantur, Alper ^a   Balci, Mustafa ^a   Gurbuz, Oguz Alp ^a   Afsar, Baris ^a   Canbakan, Basol ^a   Akdemir, Ramazan ^a   Ayli, Mehmet Deniz ^a  

^a MINISTRY OF HEALTH   (Turkey)

Author keywords

fibroblast growth factor 23; haemodialysis; left ventricular mass index; myocardial performance index

Indexed keywords

FIBROBLAST GROWTH FACTOR 23;

ADULT; AORTIC VALVE CALCIFICATION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART LEFT VENTRICLE MASS; HEART PERFORMANCE; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FUNCTION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VALVULAR HEART DISEASE;

CASE-CONTROL STUDIES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST GROWTH FACTORS; FOLLOW-UP STUDIES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RENAL DIALYSIS; RISK FACTORS;

EID: 79953880208     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq539     Document Type: Article

References (57)

1. Block GA, Klassen PS, Lazarus JM et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004; 15: 2208-2218 (Pubitemid 39031360)
2. Slinin Y, Foley RN, Collins AJ. Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study. J Am Soc Nephrol 2005; 16: 1788-1793 (Pubitemid 41716485)
3. Young EW, Albert JM, Satayathum S et al. Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study. Kidney Int 2005; 67: 1179-1187 (Pubitemid 41623345)
4. Jonsson KB, Zahradnik R, Larsson T et al. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 2003; 348: 1656-1663 (Pubitemid 36459471)
5. White KE, Jonsson KB, Carn G et al. The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting. J Clin Endo-crinol Metab 2001; 86: 497-500 (Pubitemid 32207449)
6. Saito H, Kusano K, Kinosaki M et al. Human fibroblast growth fac-tor-23 mutants suppress Na+-dependent phosphate co-transport activity and 1α, 25-dihydroxyvitamin D3 production. J Biol Chem 2003; 278: 2206-2211 (Pubitemid 36801287)
7. Imanishi Y, Inaba M, Nakatsuka K et al. FGF-23 in patients with end-stage renal disease on hemodialysis. Kidney Int 2004; 65: 1943-1946 (Pubitemid 38591047)
8. Gutiérrez OM, Isakova T, Rhee E et al. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol 2005; 16: 2205-2215 (Pubitemid 41716454)
9. Gutiérrez OM, Mannstadt M, Isakova T et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 2008; 359: 584-592
10. Gutiérrez OM, Januzzi JL, Isakova Tet al. Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation 2009; 119: 2545-2552
11. Hsu HJ, Wu MS. Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients. Am J Med Sci 2009; 337: 116-122
12. Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 1993; 4: 1205-1213
13. Chobanian AV, Bakris GL, Black HR et al. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252
14. Sahn DJ, De Maria A, Kisslo J et al. Recommendations regarding quantitation in M-mode echocardiographic measurements. Circulation 1978; 58: 1072-1083
15. Reichek N, Devereux RB. Left ventricular hypertrophy: relationship of anatomic, echocardiographic and electrocardiographic findings. Circulation 1981; 65: 99-108
16. Levy D, Savage DD, Garrison RJ et al. Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol 1987; 59: 956-960 (Pubitemid 17074242)
17. Liao Y, Cooper RS, Durazo-Arvizu R et al. Prediction of mortality risk by different methods of indexation for left ventricular mass. J Am Coll Cardiol 1997; 29: 641-647 (Pubitemid 27116109)
18. Tei C. New non-invasive index for combined systolic and diastolic ventricular function. J Cardiol 1995; 26: 135-136
19. Lakoumentas JA, Panou FK, Kotseroglou VK et al. The Tei index of myocardial performance: applications in cardiology. Hellenic J Cardiol 2005; 46: 52-58 (Pubitemid 41657714)
20. Harjai K, Scott L, Vivekananthan K et al. The Tei index: a new prognostic index for patients with symptomatic heart failure. J Am Soc Echocardiogr 2002; 15: 864-868
21. Dujardin K, Tei C, Yeo T et al. Prognostic value of a Doppler index combining systolic and diastolic performance in idiopathic-dilated cardiomyopathy. Am J Cardiol 1998; 82: 1071-1076 (Pubitemid 28507090)
22. Mooradian S, Goldberg C, Crowley D et al. Evaluation of a noninvasive index of global ventricular function to predict rejection after pediatric cardiac transplantation. Am J Cardiol 2000; 86: 358-360 (Pubitemid 30462242)
23. Ascione L, De Michele M, Accadia M et al. Myocardial global performance index as a predictor of in-hospital cardiac events in patients with first myocardial infarction. J Am Soc Echocardiogr 2003; 16: 1019-1023 (Pubitemid 37210927)
24. Haque A, Otsuji Y, Yoshifuku S et al. Effects of valve dysfunction on Doppler Tei index. J Am Soc Echocardiogr 2002; 15: 877-883
25. Eiden BW, Tei C, O'Leary PW et al. Nongeometric quantitative assessment of right and left ventricular function: myocardial performance index in normal children and patients with Ebstein anomaly. J Am Soc Echocardiogr 1998; 11: 849-856 (Pubitemid 28428101)
26. St John Sutton M, Wiegers S. The Tei index-a role in the diagnosis of heart failure? Eur Heart J 2000; 21: 1822-1824
27. Bruch C, Schmermund A, Marin D et al. Tei-index in patients with mild-to-moderate congestive heart failure. Eur Heart J 2000; 21: 1888-1895
28. Liu S, Quarles LD. How fibroblast growth factor 23 works. J Am Soc Nephrol 2007; 18: 1637-1647 (Pubitemid 46870300)
29. Larsson TB. The role of FGF-23 in CKD-MBD and cardiovascular disease: friend or foe? Nephrol Dial Transplant 2010; 25: 1376-1381
30. Jean G, Terrat JC, Vanel T et al. High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients. Nephrol Dial Transplant 2009; 24: 2792-2796
31. Silberberg JS, Barre PE, Prichard SS et al. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 1989; 36: 286-290 (Pubitemid 19202488)
32. Foley RN, Parfrey PS, Harnett JD et al. The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 1995; 5: 2024-2031
33. Tei C, Ling LH, Hodge DO et al. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function-a study in normals and dilated cardiomyopathy. J Cardiol 1995; 26: 357-366 (Pubitemid 26011184)
34. Tei C, Dujardin KS, Hodge DO et al. Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis. J Am Coll Cardiol 1996; 28: 658-664 (Pubitemid 26288647)
35. Poulsen SH, Jensen SE, Tei C et al. Value of the Doppler index of myocardial performance in the early phase of acute myocardial infarction. J Am Soc Echocardiogr 2000; 13: 723-730 (Pubitemid 30651137)
36. Tei C, Nishimura RA, Seward JB et al. Noninvasive Doppler-derived myocardial performance index: correlation with simultaneous measurements of cardiac catheterization measurements. J Am Soc Echocardiogr 1997; 10: 169-178 (Pubitemid 127789844)
37. Koga S, Ikeda S, Matsunaga K et al. Influence of hemodialysis on echocardiographic Doppler indices of the left ventricle: changes in parameters of systolic and diastolic function and Tei index. Clin Nephrol 2003; 59: 180-185 (Pubitemid 36348255)
38. Lutz JT, Giebler R, Peters J. The Tei index is preload dependent and can be measured by transesophageal echocardiography during mechanical ventilation. Eur JAnaesthesiol 2003; 20: 872-877 (Pubitemid 37376435)
39. Cheung MM, Smallhorn JE, Redington AN et al. The effects of changes in loading conditions and modulation of inotropic state on the myocardial performance index: comparison with conductance catheter measurements. Eur Heart J 2004; 25: 2238-2242 (Pubitemid 39592426)
40. Yakabe K, Ikeda S, Urata J et al. Significance of Tei-index alterations induced by acute preload reduction with hemodialysis. Clin Nephrol 2008; 70: 41-47. (Pubitemid 352005969)
41. Hughes SE. Differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal human adult tissues. J Histochem Cytochem 1997; 45: 1005-1019 (Pubitemid 27284024)
42. Hoerstrup SP, Zund G, Schnell AM et al. Optimized growth conditions for tissue engineering of human cardiovascular structures. Int J Artif Organs 2000; 23: 817-823 (Pubitemid 32058534)
43. Galzie Z, Kinsella AR, Smith JA. Fibroblast growth factors and their receptors. Biochem Cell Biol 1997; 75: 669-685 (Pubitemid 127733222)
44. Detillieux KA, Sheikh F, Kardami E et al. Biological activities of fibroblast growth factor-2 in the adult myocardium. Cardiovasc Res 2003; 57: 8-19 (Pubitemid 36009431)
45. Parker TG, Packer SE, Schneider MD. Peptide growth factors can provoke 'fetal' contractile protein gene expression in rat cardiac myocytes. J Clin Invest 1990; 85: 507-514 (Pubitemid 20070059)
46. Corda S, Mebazaa A, Gandolfini MP et al. Trophic effect of human pericardial fluid on adult cardiac myocytes. Differential role of fibroblast growth factor-2 and factors related to ventricular hypertrophy. Circ Res 1997; 81: 679-687 (Pubitemid 27467202)
47. Schultz JE, Witt SA, Nieman ML et al. Fibroblast growth factor-2 mediates pressure-induced hypertrophic response. J Clin Invest 1999; 104: 709-719 (Pubitemid 29536356)
48. Urakawa I, Yamazaki Y, Shimada T et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 2006; 444: 770-774 (Pubitemid 44949607)
49. Mirza MA, Larsson A, Melhus H et al. Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population. Atherosclerosis 2009; 207: 546-551
50. Strozecki P, Adamowicz A, Nartowicz E et al. Parathormon, calcium, phosphorus, and left ventricular structure and function in normoten-sive hemodialysis patients. Ren Fail 2001; 23: 115-126 (Pubitemid 32207300)
51. Galetta F, Cupisti A, Franzoni F et al. Left ventricular function and calcium phosphate plasma levels in uraemic patients. J Intern Med 2005; 258: 378-384 (Pubitemid 41368689)
52. Ayus JC, Mizani MR, Achinger SG et al. Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled study. J Am Soc Nephrol 2005; 16: 2778-2788
53. Hayashi SY, Brodin LA, Alvestrand A et al. Improvement of cardiac function after haemodialysis. Quantitative evaluation by colour tissue velocity imaging. Nephrol Dial Transplant 2004; 19: 1497-1506 (Pubitemid 38786744)
54. Ketteler M, Biggar PH. As nature did not predict dialysis-what we can learn from FGF23 in end-stage renal disease? Nephrol Dial Transplant 2009; 24: 2618-2620
55. Zoccali C. FGF-23 in dialysis patients: ready for prime time? Nephrol Dial Transplant 2009; 24: 1078-1081
56. Achinger SG, Ayus JC. The role of vitamin D in left ventricular hypertrophy and cardiac function. Kidney Int Suppl 2005; 95: S37-S42 (Pubitemid 43361555)
57. Artaza JN, Mehrotra R, Norris KC. Vitamin D and the cardiovascular system. Clin J Am Soc Nephrol 2009; 4: 1515-1522